Research

Dr. Mocco will lead a large team of neurosurgeons and other experts who specialize in diseases that affect the blood vessels in the brain, known as cerebrovascular disease; brain and spinal tumors; movement disorders; and other diseases of the brain, spine and nerves that branch out from the brain and spinal cord. 

Albert Einstein College of Medicine has received a five-year, $10.8 million grant from the National Institutes of Health (NIH) to create the New York Regional Diabetes Research Center (NYR-DRC), a newly expanded multi-institutional center co-led with the Icahn School of Medicine at Mount Sinai and Weill Cornell Medicine. 

Researchers at Weill Cornell Medicine have received a five-year grant from the National Institute of Diabetes and Digestive and Kidney Diseases to support TRACE, a Tool for Reproducible, Accurate Contour Estimation.

Dr. Lauren Henderson, a physician-scientist whose research focuses on children with difficult-to-treat juvenile idiopathic arthritis and other autoimmune disorders, has been awarded the 10th annual Gale and Ira Drukier Prize in Children’s Health Research, Weill Cornell Medicine announced today. 

Dr. Judy Tung, a leading expert in internal medicine and primary care, has been named chief of the Division of General Internal Medicine in the Weill Department of Medicine at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center, effective Aug. 1.

Among preterm newborns, greater exposure to the mother’s voice after birth appeared to speed up the maturation of a key language-related brain circuit, in a small clinical trial conducted by investigators at Weill Cornell Medicine, Burke Neurological Institute and Stanford Medicine.

Dr. Ekta Khurana highlights the goals of a recently paused Department of Defense grant investigating treatment-resistant prostate cancer—and the consequences of further inaction.

Home health care aides face significantly higher rates of arthritis and functional disability compared to aides working in hospitals or long-term care facilities, according to researchers at Weill Cornell Medicine and the National Institute for Occupational Safety and Health (NIOSH). 

A new tool developed by Weill Cornell Medicine and the University of Adelaide investigators has enhanced the ability to track multiple gene mutations while simultaneously recording gene activity in individual cancer cells.

Triple negative breast cancer (TNBC) is one of the most aggressive and hardest to treat breast cancers, but a new study led by Weill Cornell Medicine suggests a way to stop it from spreading.

Awards, honors and achievements for the month of September.

Most health policy experts don’t think new Medicaid work requirements introduced in the One Big Beautiful Bill Act would substantially increase employment among Medicaid-enrolled, working-age adults, according to a new survey from the Cornell Health Policy Insight Panel.

Investigators at Weill Cornell Medicine and Cornell’s Ithaca campus have received a $5.1 million, three-year grant from the National Institutes of Health’s Autism Data Science Initiative (ADSI) to launch the Autism Replication, Validation, and Reproducibility (AR²) Center.

Scientists have discovered a method to induce human endothelial cells from a small biopsy sample to multiply in the laboratory, producing more than enough cells to replace damaged blood vessels or nourish organs for transplantation, according to a preclinical study by Weill Cornell Medicine investigators.

The National Institute on Drug Abuse renewed CHERISH as a national Center of Excellence, awarding the center $10.9 million over five years to address the epidemics of substance use disorder, hepatitis C virus and HIV.

A new tool greatly improves scientists’ ability to identify and study proteins that regulate gene activity in cells, according to research led by Weill Cornell Medicine investigators.

Patients taking an experimental oral GLP-1 drug lost significant weight and improved their heart and metabolic risk factors in a large, international, phase 3 clinical trial led by investigators at Weill Cornell Medicine, McMaster University, York University and other institutions.

A multi-institutional team led by Weill Cornell Medicine investigators has been awarded a five-year, $20.8 million grant from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, for advanced preclinical development of a promising experimental HIV vaccine.

The award recognizes Dr. Nathan’s outstanding contributions that have advanced scientists’ understanding of the building blocks of innate immunity and how the immune system fights infectious diseases, including tuberculosis, and cancer.

“Kangaroo care,” or skin-to-skin contact, may be neuroprotective and is associated with neonatal development in areas of the brain involved in emotional regulation in preterm infants, according to a new preliminary study from Weill Cornell Medicine, Burke Neurological Institute and Stanford Medicine investigators.